Free release
rel-7-Bromo-6-chloro-3-(3-((2R,3S)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one

rel-7-Bromo-6-chloro-3-(3-((2R,3S)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one

CAS No. :55837-20-2MDL No. :MFCD09834143Formula :C16H17BrClN3O3Boiling Point :-Linear Structure Formula :-InChI Key :-M.

Sales:Service@apichina.com
CAS No. :55837-20-2 Brand :Qitai
Formula :C16H17BrClN3O3 M.W :414.68

Introduction

CAS No. :55837-20-2 MDL No. :MFCD09834143
Formula : C16H17BrClN3O3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 414.68 Pubchem ID :-
Synonyms :
RU-19110
Chemical Name :rel-7-Bromo-6-chloro-3-(3-((2R,3S)-3-hydroxypiperidin-2-yl)-2-oxopropyl)quinazolin-4(3H)-one

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.44
Num. rotatable bonds : 4
Num. H-bond acceptors : 5.0
Num. H-bond donors : 2.0
Molar Refractivity : 99.59
TPSA : 84.22 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.84 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.59
Log Po/w (XLOGP3) : 1.4
Log Po/w (WLOGP) : 1.5
Log Po/w (MLOGP) : 1.92
Log Po/w (SILICOS-IT) : 2.73
Consensus Log Po/w : 2.03

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.34
Solubility : 0.191 mg/ml ; 0.00046 mol/l
Class : Soluble
Log S (Ali) : -2.77
Solubility : 0.7 mg/ml ; 0.00169 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.95
Solubility : 0.00466 mg/ml ; 0.0000112 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.37
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: